Jane Marie Lundbech

Title: Jane Marie Lundbech: Inventor in Pharmaceutical Research.

Introduction

Jane Marie Lundbech is an inventor associated with Glostrup, Denmark, and Novo Nordisk A/S. Her patent work focuses on compounds and treatments related to the metabotropic glutamate receptor system.

Latest Patents

Lundbech is associated with 2 patents.

“Antagonists, Their Preparation and Use” describes therapeutically active, noncompetitive antagonists that selectively act at the metabotropic glutamate receptor. The compounds are presented as potential treatments for central nervous system diseases by modulating synaptic transmission through this receptor.

“Indole Compounds and Their Use in Treating Diseases of the Central Nervous System” concerns therapeutically active indole compounds, methods for preparing them, and pharmaceutical compositions containing them. The patent describes their potential use in treating central nervous system diseases related to the metabotropic glutamate receptor system.

Career Highlights

Lundbech’s listed patent contributions reflect research into pharmaceutical compounds and potential approaches to treating central nervous system conditions. Her work is associated with Novo Nordisk A/S.

Collaborations

Her listed coworkers include Anders Bendtz Kanstrup and Palle Jakobsen.

Conclusion

Jane Marie Lundbech’s patent record highlights pharmaceutical research focused on metabotropic glutamate receptors and potential treatments for central nervous system diseases.